Package 82009-112-12

Brand: capecitabine

Generic: capecitabine
NDC Package

Package Facts

Identity

Package NDC 82009-112-12
Digits Only 8200911212
Product NDC 82009-112
Product ID 82009-112_42afca74-0031-860a-7824-317742a8664d
Description

120 TABLET in 1 BOTTLE (82009-112-12)

Marketing

Marketing Status
Marketed Since 2023-07-21
Brand capecitabine
Generic capecitabine
Sample Package No

Linked Drug Pages (1)

Capecitabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "42afca74-0031-860a-7824-317742a8664d", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["6804DJ8Z9U"], "rxcui": ["200328"], "spl_set_id": ["d23f023a-ea62-4ac0-f615-d5d26d59526d"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Quallent Pharmaceuticals Health LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (82009-112-12)", "package_ndc": "82009-112-12", "marketing_start_date": "20230721"}], "brand_name": "Capecitabine", "product_id": "82009-112_42afca74-0031-860a-7824-317742a8664d", "dosage_form": "TABLET", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "82009-112", "generic_name": "Capecitabine", "labeler_name": "Quallent Pharmaceuticals Health LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Capecitabine", "active_ingredients": [{"name": "CAPECITABINE", "strength": "500 mg/1"}], "application_number": "ANDA204345", "marketing_category": "ANDA", "marketing_start_date": "20230721", "listing_expiration_date": "20261231"}